{
    "organizations": [],
    "uuid": "2fffc1921d76f170d33c14e83010dba7dd14ddf1",
    "author": "",
    "url": "https://www.reuters.com/article/brief-onconova-says-moving-forward-with/brief-onconova-says-moving-forward-with-pivotal-late-stage-trial-idUSASB0C17W",
    "ord_in_thread": 0,
    "title": "BRIEF-Onconova Says Moving Forward With Pivotal Late-Stage Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 51 PM / in 12 minutes BRIEF-Onconova Says Moving Forward With Pivotal Late-Stage Trial Reuters Staff 1 Min Read \nJan 17 (Reuters) - Onconova Therapeutics Inc: \n* ONCONOVA MOVING FORWARD WITH PHASE 3 INSPIRE PIVOTAL TRIAL WITH INCREASED SAMPLE SIZE FOLLOWING PROMISING INTERIM ANALYSIS \n* ONCONOVA - DMC RECOMMENDS CONTINUATION OF INSPIRE TRIAL WITH TRIAL EXPANSION PER ADAPTIVE DESIGN BASED ON INTERIM ANALYSIS RESULTS FOR OS \n* ONCONOVA - TRIAL EXECUTIVE COMMITTEE UNANIMOUSLY AGREED TO CONTINUE INTENT TO TREAT STUDY POPULATION, INCREASE CLINICAL TRIAL ENROLLMENT \n* ONCONOVA - EXPANDED INSPIRE STUDY WILL INCREASE ENROLLMENT BY ADDING 135 PATIENTS TO ORIGINAL TARGET, TO REACH TOTAL ENROLLMENT OF 360 PATIENTS Source text for Eikon: Further company coverage:",
    "published": "2018-01-17T14:51:00.000+02:00",
    "crawled": "2018-01-17T15:11:46.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "say",
        "moving",
        "forward",
        "pivotal",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "onconova",
        "therapeutic",
        "inc",
        "onconova",
        "moving",
        "forward",
        "phase",
        "inspire",
        "pivotal",
        "trial",
        "increased",
        "sample",
        "size",
        "following",
        "promising",
        "interim",
        "analysis",
        "onconova",
        "dmc",
        "recommends",
        "continuation",
        "inspire",
        "trial",
        "trial",
        "expansion",
        "per",
        "adaptive",
        "design",
        "based",
        "interim",
        "analysis",
        "result",
        "o",
        "onconova",
        "trial",
        "executive",
        "committee",
        "unanimously",
        "agreed",
        "continue",
        "intent",
        "treat",
        "study",
        "population",
        "increase",
        "clinical",
        "trial",
        "enrollment",
        "onconova",
        "expanded",
        "inspire",
        "study",
        "increase",
        "enrollment",
        "adding",
        "patient",
        "original",
        "target",
        "reach",
        "total",
        "enrollment",
        "patient",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}